Surabhi Srivastava, Commercial Head UK and EU at Qure.ai, discusses how integrating artificial intelligence can reduce chest X-ray reporting times and accelerate early lung cancer diagnosis.
Dr Arianna Di Stadio, neuroscientist and co-founder of Hello Pure, explores whether our approach to health and wellbeing has been altered in light of the coronavirus pandemic.
Özlem Bedre-Defolie, Associate Professor of Economics at ESMT Berlin, reflects on how platforms like WhatsApp and Facebook are tackling misinformation at this crucial hour.
Those newly diagnosed with Type 2 diabetes and heart failure are at the greatest 5-year risk of death, according to scientists at The American Heart Association.
In the last six months GreenLight Medicines has successfully out-licenced leads from its research, branching out internationally and attracting major investors.
Precision breeding has tailor-made new rice varieties designed to combat the double burden of malnutrition and a pesticide-free environment, according to Professor Dr Apichart Vanavichit from the Rice Science Center in Thailand.
Dr Christian Löfke, responsible for research and product development at BioBloom, walks us through the rudiments of essential oils as a potential modulator of the endocannabinoid system.
Edgar A Whitley, Professor at LSE, co-chair of PCAG and consultant on Ada Lovelace review, highlights the problems with digital immunity certificates and contact tracing apps.
Shinichi Tokuno from Voice Analysis and Measurement of Pathophysiology, Department of Bioengineering, at the University of Tokyo, tells us about an exciting aspect of voice analysis technology that concerns life events and voice biomarkers.
Therese Pei Fong Chow Research Centre for Prevention of Dementia, the Chinese University of Hong Kong, discuss if B vitamins can improve cognitive function in older people.
Doctor Allon Barsam, consultant eye surgeon and founder of Ophthalmic Consultants of London, calls attention to the unexplored devastation behind the NHS virus frontlines.
